Table 2.
Prevalence of baseline negative risk markers, and number of incident coronary heart disease and cardiovascular disease events at follow-up among participants with each negative risk marker.*
| Events at follow-up |
||||
|---|---|---|---|---|
| Prevalence at baseline |
All CHD | Hard CHD | All CVD | |
| Coronary Artery Calcium Score = 0 | 3,416 (50.1) | 74 (2.2) | 57 (1.7) | 137 (4.0) |
| Carotid Intima-Media Thickness ≤ 25th Percentile | 1,685 (25.1) | 52 (3.1) | 39 (2.3) | 80 (4.7) |
| No Carotid Plaque | 3,927 (58.5) | 191 (4.9) | 124 (3.2) | 280 (7.1) |
| Flow-Mediated Dilation ≥ 5% Change | 1,079 (35.7) | 69 (6.4) | 38 (3.5) | 89 (8.2) |
| Ankle-Brachial Index > 0.9 – < 1.3 | 6,243 (92.7) | 429 (6.9) | 266 (4.3) | 620 (9.9) |
| HsCRP < 2 mg/L | 3,496 (51.7) | 234 (6.7) | 155 (4.4) | 324 (9.3) |
| Homocysteine < 10µmol/L | 4,660 (68.6) | 279 (6.0) | 171 (3.7) | 402 (8.6) |
| NT-ProBNP < 100pg/mL | 3,988 (71.3) | 235 (5.9) | 133 (3.3) | 326 (8.2) |
| No Microalbuminuria | 6,127 (90.4) | 403 (6.6) | 258 (4.2) | 572 (9.3) |
| No Family History of CHD | 3,661 (57.3) | 204 (5.6) | 130 (3.6) | 307 (8.4) |
| No Family History of Premature CHD | 4,303 (80.5) | 301 (7.0) | 190 (4.4) | 418 (9.7) |
| No Metabolic Syndrome | 4,346 (64.0) | 245 (5.6) | 155 (3.6) | 347 (8.0) |
| Healthy Lifestyle | 1,397 (28.8) | 84 (6.0) | 56 (4.0) | 116 (8.3) |
*
Variables presented as n (%).
CHD indicates coronary heart disease; CVD, cardiovascular disease; HsCRP, high sensitivity C-reactive protein; and NT-ProBNP, N-terminal pro-brain natriuretic peptide.